Brenda Libby Coleman

Array ( [id] => 4219470 [patent_doc_number] => 06111108 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Extraction of biologically active components from Camptotheca acuminata with supercritical fluids' [patent_app_type] => 1 [patent_app_number] => 9/107713 [patent_app_country] => US [patent_app_date] => 1998-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 765 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/111/06111108.pdf [firstpage_image] =>[orig_patent_app_number] => 107713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4295441 [patent_doc_number] => 06197761 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-06 [patent_title] => '17.beta.-2-oxo-tetrahydrofuranyl)-carbothioic acid ester, -carboxylic acid ester and -carboxylic acid amide androstane derivatives' [patent_app_type] => 1 [patent_app_number] => 9/091748 [patent_app_country] => US [patent_app_date] => 1998-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20077 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/197/06197761.pdf [firstpage_image] =>[orig_patent_app_number] => 091748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4156863 [patent_doc_number] => 06114318 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-05 [patent_title] => '17.beta.-(2-oxo-tetrahydrofuranyl)-thio- substituted androstane derivatives' [patent_app_type] => 1 [patent_app_number] => 9/091747 [patent_app_country] => US [patent_app_date] => 1998-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11035 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/114/06114318.pdf [firstpage_image] =>[orig_patent_app_number] => 091747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4239699 [patent_doc_number] => 06090837 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-18 [patent_title] => 'Substituted hydrochromenopyrroles' [patent_app_type] => 1 [patent_app_number] => 9/103304 [patent_app_country] => US [patent_app_date] => 1998-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10474 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 476 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/090/06090837.pdf [firstpage_image] =>[orig_patent_app_number] => 103304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4350167 [patent_doc_number] => 06214827 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases' [patent_app_type] => 1 [patent_app_number] => 9/108124 [patent_app_country] => US [patent_app_date] => 1998-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28153 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214827.pdf [firstpage_image] =>[orig_patent_app_number] => 108124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636265 [patent_doc_number] => 06380394 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Epothilone analogs' [patent_app_type] => B1 [patent_app_number] => 09/102602 [patent_app_country] => US [patent_app_date] => 1998-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 22 [patent_no_of_words] => 59631 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/380/06380394.pdf [firstpage_image] =>[orig_patent_app_number] => 09102602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4086815 [patent_doc_number] => 06025378 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-15 [patent_title] => 'Bicyclic heterocyclic compounds' [patent_app_type] => 1 [patent_app_number] => 9/099557 [patent_app_country] => US [patent_app_date] => 1998-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10526 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/025/06025378.pdf [firstpage_image] =>[orig_patent_app_number] => 099557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4187280 [patent_doc_number] => 06093714 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-25 [patent_title] => 'Tricyclic benzazepine compounds' [patent_app_type] => 1 [patent_app_number] => 8/973991 [patent_app_country] => US [patent_app_date] => 1998-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33409 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/093/06093714.pdf [firstpage_image] =>[orig_patent_app_number] => 973991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 788181 [patent_doc_number] => 06987113 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-01-17 [patent_title] => 'Tyrosine kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 09/096014 [patent_app_country] => US [patent_app_date] => 1998-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28076 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 279 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/987/06987113.pdf [firstpage_image] =>[orig_patent_app_number] => 09096014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1560173 [patent_doc_number] => 06436917 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Non-estrogenic estradiol derivative compounds with anti-oxidative activity' [patent_app_type] => B1 [patent_app_number] => 09/092289 [patent_app_country] => US [patent_app_date] => 1998-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4016 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/436/06436917.pdf [firstpage_image] =>[orig_patent_app_number] => 09092289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3943719 [patent_doc_number] => 05981749 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Process for producing isatoic anhydrides' [patent_app_type] => 1 [patent_app_number] => 9/090858 [patent_app_country] => US [patent_app_date] => 1998-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5018 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 397 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981749.pdf [firstpage_image] =>[orig_patent_app_number] => 090858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4159033 [patent_doc_number] => 06103895 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-15 [patent_title] => 'Preparation of (11.beta.,16.beta.)-21-(acetyloxy)-11-hydroxy-2\'-methyl-5\'H-pregna-1,4-d ieno[17,16-d]oxazole-3,20-dione' [patent_app_type] => 1 [patent_app_number] => 9/077728 [patent_app_country] => US [patent_app_date] => 1998-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1950 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/103/06103895.pdf [firstpage_image] =>[orig_patent_app_number] => 077728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1325201 [patent_doc_number] => 06602864 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-05 [patent_title] => 'Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds' [patent_app_type] => B1 [patent_app_number] => 09/090492 [patent_app_country] => US [patent_app_date] => 1998-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56550 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/602/06602864.pdf [firstpage_image] =>[orig_patent_app_number] => 09090492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3946669 [patent_doc_number] => 05977135 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Bicyclic heterocycles' [patent_app_type] => 1 [patent_app_number] => 9/089019 [patent_app_country] => US [patent_app_date] => 1998-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10068 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/977/05977135.pdf [firstpage_image] =>[orig_patent_app_number] => 089019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4149393 [patent_doc_number] => 06063920 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-16 [patent_title] => 'Dinaphtazepinium salts useful as enantioselective epoxidation catalysts' [patent_app_type] => 1 [patent_app_number] => 9/011010 [patent_app_country] => US [patent_app_date] => 1998-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4532 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/063/06063920.pdf [firstpage_image] =>[orig_patent_app_number] => 011010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1534953 [patent_doc_number] => 06489322 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-03 [patent_title] => 'Amidine derivatives as inhibitors of nitric oxide synthase' [patent_app_type] => B1 [patent_app_number] => 09/068945 [patent_app_country] => US [patent_app_date] => 1998-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7081 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/489/06489322.pdf [firstpage_image] =>[orig_patent_app_number] => 09068945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4326146 [patent_doc_number] => 06329338 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Derivatives of cyclodepsipeptide PF1022 substance' [patent_app_type] => 1 [patent_app_number] => 9/043558 [patent_app_country] => US [patent_app_date] => 1998-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41516 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329338.pdf [firstpage_image] =>[orig_patent_app_number] => 043558 [rel_patent_id] =>[rel_patent_doc_number] =>)